Clavexin

Main information

  • Trade name:
  • Clavexin 125 mg/ 31.25 mg per 5 mL Powder for Suspension
  • Dosage:
  • 125 mg/ 31.25 mg per 5 mL
  • Pharmaceutical form:
  • Powder for Suspension
  • Units in package:
  • 60mL HDPE Plastic bottle w/ LDPE Tamper proof cap and 2mL Capacity PP Plastic measuring cap
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Lloyd Laboratories, Inc

Documents

Localization

  • Available in:
  • Clavexin 125 mg/31.25 mg per 5 mL Powder for Suspension
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-293-03
  • Authorization date:
  • 12-09-2019
  • Last update:
  • 15-01-2018